Skip to main content
Erschienen in: European Radiology 3/2017

01.07.2016 | Cardiac

Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm

verfasst von: Jonathan C. L. Rodrigues, Stephen Rohan, Amardeep Ghosh Dastidar, Iwan Harries, Christopher B. Lawton, Laura E. Ratcliffe, Amy E. Burchell, Emma C. Hart, Mark C. K. Hamilton, Julian F. R. Paton, Angus K. Nightingale, Nathan E. Manghat

Erschienen in: European Radiology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

European guidelines state left ventricular (LV) end-diastolic wall thickness (EDWT) ≥15mm suggests hypertrophic cardiomyopathy (HCM), but distinguishing from hypertensive heart disease (HHD) is challenging. We identify cardiovascular magnetic resonance (CMR) predictors of HHD over HCM when EDWT ≥15mm.

Methods

2481 consecutive clinical CMRs between 2014 and 2015 were reviewed. 464 segments from 29 HCM subjects with EDWT ≥15mm but without other cardiac abnormality, hypertension or renal impairment were analyzed. 432 segments from 27 HHD subjects with EDWT ≥15mm but without concomitant cardiac pathology were analyzed. Magnitude and location of maximal EDWT, presence of late gadolinium enhancement (LGE), LV asymmetry (>1.5-fold opposing segment) and systolic anterior motion of the mitral valve (SAM) were measured. Multivariate logistic regression was performed. Significance was defined as p<0.05.

Results

HHD and HCM cohorts were age-/gender-matched. HHD had significantly increased indexed LV mass (110±27g/m2 vs. 91±31g/m2, p=0.016) but no difference in site or magnitude of maximal EDWT. Mid-wall LGE was significantly more prevalent in HCM. Elevated indexed LVM, mid-wall LGE and absence of SAM were significant multivariate predictors of HHD, but LV asymmetry was not.

Conclusions

Increased indexed LV mass, absence of mid-wall LGE and absence of SAM are better CMR discriminators of HHD from HCM than EDWT ≥15mm.

Key Points

Hypertrophic cardiomyopathy (HCM) is often diagnosed with end-diastolic wall thickness ≥15mm.
Hypertensive heart disease (HHD) can be difficult to distinguish from HCM.
Retrospective case-control study showed that location and magnitude of EDWT are poor discriminators.
Increased left ventricular mass and midwall fibrosis are independent predictors of HHD.
Cardiovascular magnetic resonance parameters facilitate a better discrimination between HHD and HCM.
Literatur
1.
Zurück zum Zitat Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779CrossRefPubMed Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779CrossRefPubMed
2.
Zurück zum Zitat Gersh BJ, Maron BJ, Bonow RO et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 142:e153–e203CrossRefPubMed Gersh BJ, Maron BJ, Bonow RO et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 142:e153–e203CrossRefPubMed
3.
Zurück zum Zitat Wicker P, Roudaut R, Haissaguere M et al (1983) Prevalence and significance of asymmetric septal hypertrophy in hypertension: an echocardiographic and clinical study. Eur Heart J 4:1–5CrossRefPubMed Wicker P, Roudaut R, Haissaguere M et al (1983) Prevalence and significance of asymmetric septal hypertrophy in hypertension: an echocardiographic and clinical study. Eur Heart J 4:1–5CrossRefPubMed
4.
Zurück zum Zitat Myerson SG, Bellenger NG, Pennell DJ (2002) Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 39:750–755CrossRefPubMed Myerson SG, Bellenger NG, Pennell DJ (2002) Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 39:750–755CrossRefPubMed
5.
6.
Zurück zum Zitat Cardim N, Galderisi M, Edvardsen T et al (2015) Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging 16:280CrossRefPubMed Cardim N, Galderisi M, Edvardsen T et al (2015) Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging 16:280CrossRefPubMed
7.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219CrossRefPubMed Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219CrossRefPubMed
8.
Zurück zum Zitat Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53:284–291CrossRefPubMed Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53:284–291CrossRefPubMed
9.
Zurück zum Zitat Puntmann VO, Jahnke C, Gebker R et al (2010) Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. Am J Cardiol 106:1016–1022CrossRefPubMed Puntmann VO, Jahnke C, Gebker R et al (2010) Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. Am J Cardiol 106:1016–1022CrossRefPubMed
10.
Zurück zum Zitat Belenkov Y, Vikhert OA, Belichenko OI, Arabidze GG (1992) Magnetic resonance imaging of cardiac hypertrophy in malignant arterial hypertension. Am J Hypertens 5:195S–199SPubMed Belenkov Y, Vikhert OA, Belichenko OI, Arabidze GG (1992) Magnetic resonance imaging of cardiac hypertrophy in malignant arterial hypertension. Am J Hypertens 5:195S–199SPubMed
12.
Zurück zum Zitat Cooper LT, Baughman KL, Feldman AM et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 50(19):1914–1931 Cooper LT, Baughman KL, Feldman AM et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 50(19):1914–1931
13.
Zurück zum Zitat Maceira A, Prasad S, Khan M, Pennell D (2006) Normalized Left Ventricular Systolic and Diastolic Function by Steady State Free Precession Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson 8:417–426CrossRefPubMed Maceira A, Prasad S, Khan M, Pennell D (2006) Normalized Left Ventricular Systolic and Diastolic Function by Steady State Free Precession Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson 8:417–426CrossRefPubMed
14.
Zurück zum Zitat Childs H, Ma L, Ma M et al (2011) Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation. J Cardiovasc Magn Reson 13:40CrossRefPubMedPubMedCentral Childs H, Ma L, Ma M et al (2011) Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation. J Cardiovasc Magn Reson 13:40CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Schulz-Menger J, Bluemke DA, Bremerich J et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15:35CrossRefPubMedPubMedCentral Schulz-Menger J, Bluemke DA, Bremerich J et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15:35CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Rodriguez CJ, Diez-Roux AV, Moran A et al (2010) Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis). J Am Coll Cardiol 55:234–242CrossRefPubMedPubMedCentral Rodriguez CJ, Diez-Roux AV, Moran A et al (2010) Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis). J Am Coll Cardiol 55:234–242CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Buchner S, Debl K, Haimerl J et al (2009) Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:18. doi:10.1186/1532-429X-11-18 Buchner S, Debl K, Haimerl J et al (2009) Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:18. doi:10.​1186/​1532-429X-11-18
18.
Zurück zum Zitat Johansson B, Maceira AM, Babu-Narayan SV et al (2007) Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance. J Am Coll Cardiol 50:1294–1295CrossRefPubMed Johansson B, Maceira AM, Babu-Narayan SV et al (2007) Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance. J Am Coll Cardiol 50:1294–1295CrossRefPubMed
19.
Zurück zum Zitat Petersen SE, Selvanayagam JB, Wiesmann F, et al. (2005) Left Ventricular Non-Compaction Insights From Cardiovascular Magnetic Resonance Imaging. J Am Coll Cardiol. 46(1):101–105 Petersen SE, Selvanayagam JB, Wiesmann F, et al. (2005) Left Ventricular Non-Compaction Insights From Cardiovascular Magnetic Resonance Imaging. J Am Coll Cardiol. 46(1):101–105
20.
Zurück zum Zitat Lee PT, Dweck MR, Prasher S et al (2013) Left ventricular wall thickness and the presence of asymmetric hypertrophy in healthy young army recruits: data from the LARGE heart study. Circ Cardiovasc Imaging 6:262–267CrossRefPubMed Lee PT, Dweck MR, Prasher S et al (2013) Left ventricular wall thickness and the presence of asymmetric hypertrophy in healthy young army recruits: data from the LARGE heart study. Circ Cardiovasc Imaging 6:262–267CrossRefPubMed
21.
Zurück zum Zitat Dweck MR, Joshi S, Murigu T et al (2012) Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:50CrossRefPubMedPubMedCentral Dweck MR, Joshi S, Murigu T et al (2012) Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:50CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474CrossRefPubMed Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474CrossRefPubMed
23.
Zurück zum Zitat Chirinos JA, Segers P, De Buyzere ML et al (2010) Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 56:91–98CrossRefPubMedPubMedCentral Chirinos JA, Segers P, De Buyzere ML et al (2010) Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 56:91–98CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Sipola P, Magga J, Husso M et al (2011) Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation. Eur Radiol 21:1383–1389CrossRefPubMed Sipola P, Magga J, Husso M et al (2011) Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation. Eur Radiol 21:1383–1389CrossRefPubMed
25.
Zurück zum Zitat Olivotto I, Maron MS, Autore C et al (2008) Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52:559–566CrossRefPubMed Olivotto I, Maron MS, Autore C et al (2008) Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52:559–566CrossRefPubMed
26.
Zurück zum Zitat Rodrigues JCL, Amadu AM, Dastidar AG et al (2015) Prevalence and predictors of asymmetric hypertensive heart disease: insights from cardiac and aortic function with cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. doi:10.1093/ehjci/jev329 Rodrigues JCL, Amadu AM, Dastidar AG et al (2015) Prevalence and predictors of asymmetric hypertensive heart disease: insights from cardiac and aortic function with cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. doi:10.​1093/​ehjci/​jev329
27.
Zurück zum Zitat Moon JCC, Fisher NG, McKenna WJ, Pennell DJ (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649CrossRefPubMedPubMedCentral Moon JCC, Fisher NG, McKenna WJ, Pennell DJ (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Frielingsdorf J, Franke A, Kühl HP et al (2001) Evaluation of septal hypertrophy and systolic function in diseases that cause left ventricular hypertrophy: a 3-dimensional echocardiography study. J Am Soc Echocardiogr 14:370–377CrossRefPubMed Frielingsdorf J, Franke A, Kühl HP et al (2001) Evaluation of septal hypertrophy and systolic function in diseases that cause left ventricular hypertrophy: a 3-dimensional echocardiography study. J Am Soc Echocardiogr 14:370–377CrossRefPubMed
29.
Zurück zum Zitat Kuruvilla S, Janardhanan R, Antkowiak P et al (2015) Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging 8:172–180CrossRefPubMedPubMedCentral Kuruvilla S, Janardhanan R, Antkowiak P et al (2015) Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging 8:172–180CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Varnava AM, Elliott PM, Sharma S et al (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482CrossRefPubMedPubMedCentral Varnava AM, Elliott PM, Sharma S et al (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Treibel TA, Zemrak F, Sado DM et al (2015) Extracellular volume quantification in isolated hypertension - changes at the detectable limits? J Cardiovasc Magn Reson 17:74CrossRefPubMedPubMedCentral Treibel TA, Zemrak F, Sado DM et al (2015) Extracellular volume quantification in isolated hypertension - changes at the detectable limits? J Cardiovasc Magn Reson 17:74CrossRefPubMedPubMedCentral
32.
33.
Zurück zum Zitat Hinojar R, Varma N, Child N et al (2015) T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging. doi:10.1161/CIRCIMAGING.115.003285 PubMed Hinojar R, Varma N, Child N et al (2015) T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging. doi:10.​1161/​CIRCIMAGING.​115.​003285 PubMed
34.
Zurück zum Zitat De Marvao A, Dawes TJW, Shi W et al (2015) Precursors of Hypertensive Heart Phenotype Develop in Healthy Adults. JACC Cardiovasc Imaging 8:1260–1269CrossRefPubMedPubMedCentral De Marvao A, Dawes TJW, Shi W et al (2015) Precursors of Hypertensive Heart Phenotype Develop in Healthy Adults. JACC Cardiovasc Imaging 8:1260–1269CrossRefPubMedPubMedCentral
Metadaten
Titel
Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm
verfasst von
Jonathan C. L. Rodrigues
Stephen Rohan
Amardeep Ghosh Dastidar
Iwan Harries
Christopher B. Lawton
Laura E. Ratcliffe
Amy E. Burchell
Emma C. Hart
Mark C. K. Hamilton
Julian F. R. Paton
Angus K. Nightingale
Nathan E. Manghat
Publikationsdatum
01.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 3/2017
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4468-2

Weitere Artikel der Ausgabe 3/2017

European Radiology 3/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.